Uncoupling of serotonergic and noradrenergic systems in depression: Preliminary evidence from continuous cerebrospinal fluid sampling

Depression and Anxiety

Volumn 6, Issue 3, 1997, Pages 89-94

  Geracioti Jr , Thomas D ^a,b   Loosen, Peter T ^c   Ekhator, Nosa N ^a,b   Schmidt, Dennis ^c   Chambliss, Bryon ^c   Baker, Dewleen G ^a,b   Kasckow, John W ^a,b   Richtand, Neil M ^a,b   Keck Jr , Paul E ^a,b   Ebert, Michael H ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

3 methoxy 4 hydroxyphenylglycol (MHPG); 5 hydroxyindoleacetic acid (5 HIAA); Cerebrospinal fluid (CSF); Norepinephrine (Noradrenaline); Serotonin (5 hydroxytryptamine); Tryptophan

Indexed keywords

4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; 5 HYDROXYINDOLEACETIC ACID; NORADRENALIN; SEROTONIN; TRYPTOPHAN;

ADULT; ARTICLE; BRAIN REGION; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; MALE; NORADRENERGIC SYSTEM; PATHOGENESIS; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM;

ADULT; ANALYSIS OF VARIANCE; BIOGENIC MONOAMINES; DEPRESSIVE DISORDER; FEMALE; HUMANS; HYDROXYINDOLEACETIC ACID; MALE; METHOXYHYDROXYPHENYLGLYCOL; NOREPINEPHRINE; SEROTONIN; TRYPTOPHAN;

EID: 6844257532     PISSN: 10914269     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6394(1997)6:3<89::AID-DA1>3.0.CO;2-0     Document Type: Article

References (35)

1. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R). Washington, DC: American Psychiatric Press.
2. Anderson GM, Mefford IN, Tolliver TJ, Riddle MA, Ocame DM, Leckman JF, Cohen DJ (1990) Serotonin in human lumbar cerebrospinal fluid: A reassessment. Life Sci 46:247-255.
3. Asberg M, Thoren P, Traskman L, Bertilsson L, Ringberger V (1986) Cerebrospinal fluid studies in suicide: An overview. In Mann JJ, Stanley M (eds): Psychobiology of Suicidal Behavior. New York: New York Academy of Sciences.
4. Ashton-Jones G, Akaoka H, Charlety P, Chouvet G (1991) Serotonin selectively attenuates glutamate-evoked activation of noradrenergic locus coeruleus neurons. J Neurosci 11:760-769.
5. Breier A, Wolkowitz OM, Doran AR, Bellar S, Pickar D (1988) Neurobiological effects of lumbar puncture stress in psychiatric patients and healthy volunteers. Psychiatry Res 25:187-194.
6. Christensen NJ, Vestergaard P, Sorensen T, Rafaelsen OJ (1980) Cerebrospinal fluid adrenaline and noradrenaline in depressed patients. Acta Psychiatr Scand 61:178-182.
7. Davis JM, Koslow SII, Gibbons RD, Maas JW, Bowden CL. Casper RC, Hanin I, Javaid JI, Chang SS, Stokes PE (1988) Cerebrospinal fluid and urinary biogenic amines in depressed patients and healthy controls. Arch Gen Psychiatry 45:705-717.
8. DeBellis MD, Geracioti TD Jr, Altemus M, Kling MA (1993) Cerebrospinal fluid monoamine metabolites in fluoxetine-treated patients with major depression and in healthy volunteers. Biol Psychiatry 33:636-641.
9. Engberg G (1992) Citalopram and 8-OH-DPAT attenuate nicotine-induced excitation of central noradrenaline neurons. J Neural Transm 89:149-154.
10. Feuerstein TJ, Weidenfeld (1993) Endogenous n oradrenaline activates alpha2-adrenoceptors on serotonergic nerve endings in human and rat neocortex. J Neurochem 61:474-480.
11. Geracioti TD Jr, Schmidt D, Ekhator NN, Shelton R, Parris W, Loosen PT, Ebert MH (1993) Cerebrospinal fluid norepinephrine concentrations and dynamics in depressed patients and normal volunteers. Depression 1:149-155.
12. Geracioti TD Jr, Loosen PT, Ebert MH, Ekhator NN, Burns D, Nicholson WE, Orth DN (1994) Concentrations of corticotropin-releasing hormone, norepinephrine, MHPG, 5-Hydroxyindoleacetic acid, and tryptophan in the cerebrospinal fluid of alcoholic patients: Serial sampling studies. Neuroendocrinology 60:635-642.
13. Gjerris A, Werdelin L, Rafaelsen OJ, Allinng C, Christensen NJ (1987) CSF dopamine increased in depression: CSF dopamine, noradrenaline and their metabolites in depressed patients and in controls. J Affect Dis 13:279-286.
14. Hsiao JK, Agren H, Bartko JJ, Rudorfer MV, Linnoila M, Potter WZ (1987) Monoamine neurotransmitter interactions and the prediction of antidepressant response. Arch Gen Psychiatry 44:1078-1083.
15. Hsiao JK, Potter WZ, Agren H, Owen RR, Pickar D (1993) Clinical investigation of monoamine neurotransmitter interactions. Psychopharmacology 112:S76-S84.
16. Jibson M, Faull KF, Csernansky JG (1990) Intercorrelations among monoamine metabolite concentrations in human lumbar CSF are not due to a shared acid transport system. Biol Psychiatry 28:595-602.
17. Kirwin PD, Anderson GM, Chappell PB, Saberski L, Leckman JF, Geracioti TD, Henninger GR, Price LH, McDougle CJ (1997) Assessment of diurnal variation of cerebrospinal fluid tryptophan and 5-hydroxyindoleacetic acid concentrations in healthy human females. Life Sci 60.899-907.
18. Koslow SH, Maas JW, Bowden CL, Davis JM, Hanin I, Javaid J (1983) CSF and urinary biogenic amines and metabolites in depression and mania. A controlled, univariate analysis. Arch Gen Psychiatry 40:999-1010.
19. Maes M, Meltzer HY (1995) The serotonin hypothesis of major depression. In bloom FE, Kupfer DJ (eds): Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press, p. 933-944.
20. Meltzer HY, Lowy MT (1987) The serotonin hypothesis of depression. In Meltzer HY (ed): Psychopharmacology: The Third Generation of Progress. New York: Raven Press, p 513-526.
21. Nicoletti F, Raffaele R, Falsaperla A, Paci R (1981) Circadian variation in 5-hydroxyindoleacetic acid levels in human cerebrospinal fluid. Eur Neurol 20:9-12.
22. Owens MJ, Nemeroff CB (1994) Role of serotonin in the pathophysiology of depression: Focus on the role of the serotonin transporter. Clin Chem 40:288-295.
23. Post RM, Lake CR, Jimerson DC, Bunney WE, Wood JH, Ziegler MG, Goodwin FK (1978) Cerebrospinal fluid norepinephrine in affective illness. Am J Psychiatry 135:907-912.
24. Potter WZ, Manji HK (1994) Catecholamines in depression: An update. Clin Chem 40:279-287.
25. Porter WZ, Scheinin M, Golden RN, Rudorfer MV, Cowdry RW, Calil HM, Ross RJ, Linnoila M (1985) Selective antidepressants and cerebrospinal fluid. Lack of specificity on norepinephrine and serotonin metabolites. Arch Gen Psychiatry 42:1171-1177.
26. Roy A, Linnoila M (1988) Suicidal behavior, impulsivity, and serotonin. Acta Psychiatr Scand 78:2609-2614.
27. Roy AR, Pickar D, DeJong J, Karoum F, Linnoila M (1988) Norepinephrine an dits metabolites in cerebrospinal fluid, plasma, and urine. Arch Gen Psychiatry 45:849-857.
28. Schmidt D, Roznoski M, Ebert MH (199) Qualitative and quantitative high performance liquid chromatographic analysis of monoamine neurotransmitters and metabolites in cerebrospinal fluid and brain tissue using reductive electrochemical detection. Biomed Chromatogr 4:215-220.
29. Snedecor GW, Cochran WG (1967) Statistical methods. Ames, Iowa: Iowa State University Press.
30. Spitzer RL, Williams JBW, Gibbon M, First MB (1990) Structured Clinical Interview for DSM-III-R. Washington, DC: American Psychiatric Press.
31. Sulser F (1987) Serotonin-norepinephrine receptor interactions in the brain: Implications for the pharmacology and pathophysiology of affective disorders. J Clin Psychiatry 48(3, Suppl):12-18.
32. Sulser F (1989) New perspectives on the molecular pharmacology of affective disorders. Eur Arch Psychiatr Neurol Sci 238:231-239.
33. Taylor PL, Garrick NA, Burns RS, Ramarkin L, Murphy DL, Markey SP (1982) Diurnal rhythms of serotonin in monkey cerebrospinal Fluid. Life Sci 31:1993-1999.
34. Tian Y, Goudreau JL, Lookingland KJ, Moore KE (1993) Neurochemical evidence that 5-hydroxytryptamine neurons tonically inhibit noradrenergic neurons terminating in the hypothalamus. Brain Res 607:467-506.
35. Wood JH (1980) Physiology, pharmacology, and dynamics of cerebrospinal fluid. In Wood JH (ed): Neurobiology of Cerebrospinal Fluid. New York: Plenum Press, pp 1-16.